Advertisement

Telogen Effluvium

  • Pooya Khan Mohammad Beigi
Chapter

Abstract

Telogen effluvium occurs due to a shift in the hair cycle away from the anagen phase and into the catagen stage and afterward to telogen [2]. This state includes increased shedding of telogen hairs, which can be evaluated using the validated visual analog scales [3].

Keywords

Anagen phase Catagen phase Telogen phase Analog scale Diffuse hair loss Immediate anagen release Anagen phase Telogen phase Delayed anagen release Postpartum hair Short anagen syndrome Immediate telogen release Minoxidil Delayed telogen release Triggering event Hair pull test Inner root sheaths Thyroid disorders Iron-deficiency anemia Acrodermatitis enteropathica Systemic lupus erythematosus Dermatomyositis Malnutrition Heparin retinoid Beta blockers Captopril Allopurinol Boric acid Phenytoin Glibenclamide Amphetamines Levodopa Bromocriptine Methysergide Albendazole/mebendazole Cimetidine Colchicine Sulfasalazine Penicillamine Gold Diffuse alopecia areata Congenital atrichia Loose anagen syndrome Congenital hypotrichosis Anagen effluvium Stemoxydine Nioxin Minoxidil CNPDA Anemia Iron deficiency Iron supplementation 

References

  1. 1.
    Liyanage D, Sinclair R. Telogen Effluvium. Cosmetics. 2016;3(2):13.CrossRefGoogle Scholar
  2. 2.
    Sinclair R. Hair shedding in women: how much is too much? Br J Dermatol. 2015;173(3):846–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Headington JT. Telogen effluvium: new concepts and review. Arch Dermatol. 1993;129(3):356–63.CrossRefPubMedGoogle Scholar
  4. 4.
    Trüeb RM. Systematic approach to hair loss in women. JDDG: J Dtsch Dermatol Ges. 2010;8(4):284–97.PubMedGoogle Scholar
  5. 5.
    Harrison S, Sinclair R. Telogeneffluvium. H&G Z Hautkr. 2002;77(7–8):351–8.CrossRefGoogle Scholar
  6. 6.
    Kligman AM. Pathologic dynamics of human hair loss: I. Telogen effluvium. Arch Dermatol. 1961;83(2):175–98.CrossRefPubMedGoogle Scholar
  7. 7.
    Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol. 2013;79(5):591.CrossRefPubMedGoogle Scholar
  8. 8.
    Piérard-franchimont C, Peérard G. L’effluvium télogène actinique: une facette de la chronobiologie humaine. Int J Cosmet Sci. 1999;21(1):15–21.CrossRefPubMedGoogle Scholar
  9. 9.
    Buhl AE. Minoxidil's action in hair follicles. J Investig Dermatol. 1991;96(5):S73–S4.CrossRefGoogle Scholar
  10. 10.
    Davis M, Thomas J, Van de Velde S, Boissy Y, Dawson T, Iveson R, et al. A novel cosmetic approach to treat thinning hair. Br J Dermatol. 2011;165(s3):24–30.CrossRefPubMedGoogle Scholar
  11. 11.
    Karadağ AS, Ertuğrul DT, Tutal E, Akin KO. The role of anemia and vitamin D levels in acute and chronic telogen effluvium. Turk J Med Sci. 2011;41(5):827–33.Google Scholar
  12. 12.
    Rushton D. Nutritional factors and hair loss. Clin Exp Dermatol. 2002;27(5):396–404.CrossRefPubMedGoogle Scholar
  13. 13.
    Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol. 2002;147(5):982–4.CrossRefPubMedGoogle Scholar
  14. 14.
    Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Investig Dermatol. 2003;121(5):985–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Pooya Khan Mohammad Beigi
    • 1
    • 2
    • 3
  1. 1.Department of Health ManagementNew York Medical CollegeValhallaUSA
  2. 2.University of British ColumbiaVancouverCanada
  3. 3.Misdiagnosis AssociationSeattleUSA

Personalised recommendations